CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
- 31 May 2024
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 595, 217006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted TherapiesHepatology, 2020
- Emerging Roles for Branched-Chain Amino Acid Metabolism in CancerCancer Cell, 2020
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular CarcinomaCell, 2019
- Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase InhibitorsCell Reports, 2019
- Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase ActivityCell Reports, 2018
- Prospero‐related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin‐8 expressionHepatology, 2017
- Comprehensive and Integrative Genomic Characterization of Hepatocellular CarcinomaCell, 2017
- Cellular Fatty Acid Metabolism and CancerCell Metabolism, 2013
- PROX1 Promotes Hepatocellular Carcinoma Metastasis By Way of Up-Regulating Hypoxia-Inducible Factor 1α Expression and Protein StabilityHepatology, 2013
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008